ittrium [90y]-szilikát injekció
amersham plc - radiofarmakon terápiás célra -
epirubicin kabi 2 mg/ml oldatos injekció vagy infúzió
fresenius kabi oncology plc. - epirubicin-hidroklorid -
zolacitor 4 mg/5 ml koncentrátum oldatos infúzióhoz
chiesi pharmaceuticals gmbh - zoledronsav -
oxaliplatin kabi 5 mg/ml por oldatos infúzióhoz
fresenius kabi oncology plc. - oxaliplatin -
letrozol kabi 2,5 mg filmtabletta
fresenius kabi oncology plc. - letrozol -
fayton 4 mg/100 ml oldatos infúzió
glenmark pharmaceuticals s.r.o. - zoledronsav -
fayton 4 mg/5 ml koncentrátum oldatos infúzióhoz
glenmark pharmaceuticals s.r.o. - zoledronsav -
fludarabin kabi 50 mg por oldatos injekcióhoz vagy infúzióhoz
fresenius kabi oncology plc. - fludarabine foszfát -
pamidronate hospira 3 mg/ml koncentrátum oldatos infúzióhoz, 10 ml
mayne pharma plc - pamidronic sav -
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immunrendszer sera, immunglobulinok, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.